Health
Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19 – News-Medical.Net
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
A pandemic spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for almost one million deaths due to COVID-19. Therefore, important insights into the viral pathophysiology may facilitate the quest for an eff…
-
Noosa News23 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General23 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
General9 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General23 hours agoDonald Trump didn’t receive the Nobel Peace Prize. Experts say he had ‘no chance’ at winning